Taysha Gene Therapies (TSHA) Asset Utilization Ratio: 2022-2025
Historic Asset Utilization Ratio for Taysha Gene Therapies (TSHA) over the last 3 years, with Sep 2025 value amounting to 0.02.
- Taysha Gene Therapies' Asset Utilization Ratio fell 62.82% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 62.82%. This contributed to the annual value of 0.05 for FY2024, which is 51.59% down from last year.
- Per Taysha Gene Therapies' latest filing, its Asset Utilization Ratio stood at 0.02 for Q3 2025, which was down 43.58% from 0.03 recorded in Q2 2025.
- Taysha Gene Therapies' 5-year Asset Utilization Ratio high stood at 0.09 for Q1 2024, and its period low was -0.03 during Q4 2022.
- Moreover, its 3-year median value for Asset Utilization Ratio was 0.05 (2023), whereas its average is 0.05.
- Per our database at Business Quant, Taysha Gene Therapies' Asset Utilization Ratio soared by 526.79% in 2024 and then crashed by 62.82% in 2025.
- Quarterly analysis of 4 years shows Taysha Gene Therapies' Asset Utilization Ratio stood at -0.03 in 2022, then skyrocketed by 362.47% to 0.08 in 2023, then slumped by 41.65% to 0.05 in 2024, then plummeted by 62.82% to 0.02 in 2025.
- Its last three reported values are 0.02 in Q3 2025, 0.03 for Q2 2025, and 0.05 during Q1 2025.